Literature DB >> 9231461

Nuclear DNA in histological and cytological specimens: measurement and prognostic significance.

D P Magennis1.   

Abstract

In recent years molecular biology techniques have provided new insights into the nuclear mechanisms associated with carcinogenesis. These have led to renewed interest in the measurement of nuclear DNA for diagnosis, prediction of prognosis, and assessing tumour response to therapy. Cytogenetics has been used successfully for this purpose for several decades, but technical problems have largely restricted this to haematological malignancies. However, technological improvements in flow cytometry and image analysis, together with new molecular biology techniques for measuring nuclear DNA, are providing useful information on nuclear ploidy and proliferative activity in solid tumours. Although many problems remain in this field, these new and improved techniques for measuring nuclear DNA are beginning to find a role in diagnostic pathology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231461

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  3 in total

1.  DNA-flow cytometry of 207 pituitary adenomas: ploidy, proliferation, and prognosis.

Authors:  A L O Machado; P Nomikos; F Kiesewetter; R Fahlbusch; M Buchfelder
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.

Authors:  Selma Yildirim-Assaf; Alexandra Coumbos; Werner Hopfenmüller; Hans-Dieter Foss; Harald Stein; Wolfgang Kühn
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

3.  Characterisation of breast fine-needle aspiration biopsies by centrosome aberrations and genomic instability.

Authors:  U Kronenwett; S Huwendiek; J Castro; T Ried; G Auer
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.